We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light - a Randomized Controlled Trial

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2008 by Bispebjerg Hospital.
Recruitment status was:  Active, not recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00254280
First Posted: November 16, 2005
Last Update Posted: June 2, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Bispebjerg Hospital
  Purpose
The purpose of the study is for recalcitrant hand and foot warts to compare the efficacy of treatment with Intense Pulsed Light and paring versus paring alone.

Condition Intervention
Warts Procedure: Intense Pulsed Light + paring versus paring alone

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Official Title: Treatment of Recalcitrant Hand and Foot Warts With Intense Pulsed Light and Paring Versus Paring Alone - a Randomized Controlled Trial With Blinded Response Evaluation

Resource links provided by NLM:


Further study details as provided by Bispebjerg Hospital:

Study Start Date: November 2005
Estimated Study Completion Date: September 2008
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years or older
  • Recalcitrant warts
  • No previous IPL treatment of warts

Exclusion Criteria:

  • Immunosuppressive treatment
  • Patients suffering from HIV, diabetes or other immunosuppressive diseases
  • Pregnancy
  • Previous IPL treatment
  • Patients with a tendency to prodyce keloids or hypertrophic scars
  • Mosaic and flat warts
  • Lack of informed consent
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00254280


Locations
Denmark
Bispebjerg hospital
Copenhagen, Copenhagen NV, Denmark, 2400
Sponsors and Collaborators
Bispebjerg Hospital
Investigators
Principal Investigator: Merete Haedersdal, MD, PhD, DrMedSci Bispebjerg Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00254280     History of Changes
Other Study ID Numbers: KF-01-255566
First Submitted: November 15, 2005
First Posted: November 16, 2005
Last Update Posted: June 2, 2008
Last Verified: May 2008

Keywords provided by Bispebjerg Hospital:
Warts
Intense pulsed light
RCT
Recalcitrant hand and foot warts

Additional relevant MeSH terms:
Warts
Papillomavirus Infections
DNA Virus Infections
Virus Diseases
Skin Diseases, Viral
Tumor Virus Infections
Skin Diseases, Infectious
Skin Diseases